Fosun’s Henlius Is Said in Talks With J&J, Roche on Cancer Drug
PositiveFinancial Markets

Shanghai Henlius Biotech is negotiating with Johnson & Johnson and Roche to sell rights to an experimental cancer drug.
Editor’s Note: This development is significant as it could lead to new treatment options for cancer patients and highlights the ongoing collaboration between biotech firms and major pharmaceutical companies.
— Curated by the World Pulse Now AI Editorial System